Ipswich Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shell
SHEL
|
+$1.18M |
| 2 |
ASML
ASML
|
+$967K |
| 3 |
Intel
INTC
|
+$912K |
| 4 |
Illumina
ILMN
|
+$891K |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$726K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Akamai
AKAM
|
+$2.01M |
| 2 |
Guardant Health
GH
|
+$1.5M |
| 3 |
Microsoft
MSFT
|
+$1.36M |
| 4 |
Intellia Therapeutics
NTLA
|
+$1.23M |
| 5 |
Apple
AAPL
|
+$1.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.42% |
| 2 | Healthcare | 16.83% |
| 3 | Consumer Staples | 12.39% |
| 4 | Industrials | 12.02% |
| 5 | Financials | 9.74% |
Similar funds
Ipswich Investment Management's Q1 2022 Portfolio in Review
As of Q1 2022, Ipswich Investment Management held 205 positions worth $403M, down 6% from $429M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ipswich Investment Management withdrew a net $12.3M in Q1 2022, closing 16 positions and reducing 81 holdings. Its most notable exit was Guardant Health, an estimated $1.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Ipswich Investment Management opened a new position in Shell worth $1.22M.
- Ipswich Investment Management's largest Q1 2022 buy was Shell: 22,273 shares worth $1.22M.
- Ipswich Investment Management added most to ASML in Q1 2022, an estimated $967K increase.
- Ipswich Investment Management's biggest Q1 2022 reduction was Akamai, cutting an estimated $2.01M.
- Ipswich Investment Management fully exited Guardant Health in Q1 2022, selling an estimated $1.5M.
- Ipswich Investment Management's ten largest holdings make up 29% of its $403M portfolio in Q1 2022.
- Ipswich Investment Management opened 5 new positions and closed 16 in Q1 2022.
- Ipswich Investment Management's portfolio value fell 6% quarter-over-quarter to $403M.
Based on Ipswich Investment Management's 13F filing for Q1 2022, filed 12 Apr 2022.